Dengue is a mosquito-borne infectious disease that affects both animals and humans, it is caused by the dengue virus that belongs to the family of Flaviviridae and genus Flavivirus.
The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.
The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.
The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.
